(AOF) – “On April 1, we successfully finalized the acquisition of Sasaeah,” announces Virbac. The animal health specialist emphasizes that this acquisition announced on March 6 will bring it “a leading position in the market for vaccines for farmed animals in Japan, particularly in the cattle segment, and a broad portfolio of pharmaceutical products for all the main species. Virbac will benefit from Sasaeah’s production sites in Japan and Vietnam, its R&D capabilities as well as more than 500 employees.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
